Stockreport

MiNK Therapeutics Inc (INKT) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF Net Loss: $1.8 million or 5 per share for the three months; $8.3 million or 22 per share for the nine months ended September 30, 2024. Net Loss Comparison: $5.1 milli [Read more]